Inspec

Inspec Current Liabilities

The Current Liabilities of Inspec (6656.T) as of Nov 13, 2026 is 2.11 B JPY. In the previous year, Current Liabilities was 1.64 B JPY — a change of 28.77% (higher).

Current Liabilities

2.11 BJPY

YoY

28.77%

Last updated:

Current Liabilities of Inspec is 2026 2.11 B JPY. Current Liabilities of Inspec was 2025 1.64 B JPY. It decreases by 28.77% higher compared to the previous year.

The Inspec Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
1.71 B JPY
Jan 1, 2020
1.30 B JPY
Jan 1, 2021
646.45 M JPY
Jan 1, 2022
1.18 B JPY
Jan 1, 2023
1.74 B JPY
Jan 1, 2024
2.05 B JPY
Jan 1, 2025
1.64 B JPY
Jan 1, 2026
2.11 B JPY
The Inspec Current Liabilities history
YEARCurrent LiabilitiesYoY
2.11 BJPY+28.77%
1.64 BJPY-20.22%
2.05 BJPY+18.15%
1.74 BJPY+47.96%
1.18 BJPY+81.79%
646.45 MJPY-50.25%
1.30 BJPY-24.22%
1.71 BJPY+40.34%
1.22 BJPY-4.50%
1.28 BJPY+54.78%
826.63 MJPY+4.69%
789.57 MJPY+79.75%
439.27 MJPY+69.88%
258.58 MJPY-36.11%
404.75 MJPY+7.11%
377.89 MJPY-6.50%
404.16 MJPY+187.30%
140.68 MJPY-68.02%
439.89 MJPY-66.15%
1.30 BJPY+17.90%
1.10 BJPY+23.55%
892.00 MJPY+21.43%
734.60 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Current Liabilities of Inspec is 2.11 B JPY in 2026.

Current Liabilities of Inspec changed from 1.64 B JPY to 2.11 B JPY, representing a 28.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Inspec since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Inspec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Inspec

All Key Metrics — Inspec